A randomized controlled study into the efficacy and toxicity of pegylated liposome encapsulated doxorubicin as an adjuvant therapy in dogs with splenic haemangiosarcoma-Reference-Cited by-同舟云学术

A randomized controlled study into the efficacy and toxicity of pegylated liposome encapsulated doxorubicin as an adjuvant therapy in dogs with splenic haemangiosarcoma

Published:2011-04-18 Issue:4 Volume:9 Page:283-289
ISSN:1476-5810
Container-title:Veterinary and Comparative Oncology
language:en
Short-container-title:

Author:

Teske E.,Rutteman G. R.,Kirpenstein J.,Hirschberger J.

Publisher

Wiley

Subject

General Veterinary

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1476-5829.2011.00266.x/fullpdf

Reference33 articles.

1. Epidemiologic, clinic, pathologic, and prognostic characteristics of splenic hemangiosarcoma and splenic hematoma in dogs: 217 cases (1985).;Prymak;Journal of the American Veterinary Medical Association,1988

2. Canine hemangiosarcoma: Retrospective analysis of 104 cases.;Brown;Journal of the American Veterinary Medical Association,1985

3. Haemangiosarcoma in dogs.;Oksanen;Journal of Comparative Pathology,1978

4. Breed prevalence and sites of hemangioma and hemangiosarcoma in dogs.;Srebernik;The Veterinary Record,1991

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prospective study of successful autologous dendritic cell therapy in dogs with splenic stage II hemangiosarcoma;The Veterinary Journal;2024-08

2. Panobinostat-loaded folate targeted liposomes as a promising drug delivery system for treatment of canine B-cell lymphoma;Frontiers in Veterinary Science;2023-08-30

3. PEG-liposomal doxorubicin as a potential agent for canine metastatic osteosarcoma – in vitro and ex ovo studies;Journal of Veterinary Research;2023-06-01

4. Diagnosis, Prognosis, and Treatment of Canine Hemangiosarcoma: A Review Based on a Consensus Organized by the Brazilian Association of Veterinary Oncology, ABROVET;Cancers;2023-03-29

5. Pilot safety evaluation of doxorubicin chemotherapy combined with non-specific immunotherapy (Immunocidin®) for canine splenic hemangiosarcoma;PLOS ONE;2022-12-22